Suarez 2008.
Study characteristics | |||
Patient sampling | Prospective study; consecutive enrolment; singe group | ||
Patient characteristics and setting | All adult patients receiving allogeneic or autologous HSCT, or intensive chemotherapy for haematological malignancies, and who were routinely monitored for biweekly GM detection were included in the study "This study was conducted prospectively […] in the adult hematology and bone marrow transplant unit at […] a tertiary‐care university hospital (Paris, France)" Representative spectrum? Yes: seems to be eligible (consecutive enrollment; all suspected of IPA) |
||
Index tests | "The GM assay was performed […] twice weekly […] using the Platelia Aspergillus enzyme immunoassay (Bio‐Rad Laboratories, Marnes‐la‐Coquette, France). Serum samples with an index of >0.5 were retested the following day and were considered positive if the GM index was again >0.5" | ||
Target condition and reference standard(s) | Invasive aspergillosis, as defined by EORTC criteria (Ascioglu 2002) Incorporation avoided? Yes: we used the EORTC/MSG criteria (except the GM results) for diagnosis of IA Acceptable reference standard? Yes: EORTC criteria |
||
Flow and timing | Study lasted 13 months Partial verification avoided? Yes Withdrawals explained? Seems as if there were no withdrawals (N/A) Uninterpretable results reported? Yes: seems that there were no indeterminates etc. (so N/A) |
||
Comparative | |||
No patients per category | 1 proven, 14 probable, 2 possible, 107 no IA | ||
Notes | Support has been reported; no Platelia support mentioned | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Low | Low | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Low |